1. Home
  2. MRUS vs EQX Comparison

MRUS vs EQX Comparison

Compare MRUS & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • EQX
  • Stock Information
  • Founded
  • MRUS 2003
  • EQX 2007
  • Country
  • MRUS Netherlands
  • EQX Canada
  • Employees
  • MRUS N/A
  • EQX N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • EQX Precious Metals
  • Sector
  • MRUS Health Care
  • EQX Basic Materials
  • Exchange
  • MRUS Nasdaq
  • EQX Nasdaq
  • Market Cap
  • MRUS 2.7B
  • EQX 3.2B
  • IPO Year
  • MRUS 2016
  • EQX N/A
  • Fundamental
  • Price
  • MRUS $40.90
  • EQX $6.44
  • Analyst Decision
  • MRUS Strong Buy
  • EQX
  • Analyst Count
  • MRUS 14
  • EQX 0
  • Target Price
  • MRUS $87.00
  • EQX N/A
  • AVG Volume (30 Days)
  • MRUS 770.0K
  • EQX 12.4M
  • Earning Date
  • MRUS 05-07-2025
  • EQX 05-07-2025
  • Dividend Yield
  • MRUS N/A
  • EQX N/A
  • EPS Growth
  • MRUS N/A
  • EQX N/A
  • EPS
  • MRUS N/A
  • EQX 0.64
  • Revenue
  • MRUS $54,732,000.00
  • EQX $1,696,526,000.00
  • Revenue This Year
  • MRUS $26.81
  • EQX $41.27
  • Revenue Next Year
  • MRUS $23.85
  • EQX $14.35
  • P/E Ratio
  • MRUS N/A
  • EQX $10.05
  • Revenue Growth
  • MRUS 42.77
  • EQX 54.88
  • 52 Week Low
  • MRUS $33.19
  • EQX $4.48
  • 52 Week High
  • MRUS $61.61
  • EQX $7.45
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 45.06
  • EQX 46.40
  • Support Level
  • MRUS $37.92
  • EQX $6.06
  • Resistance Level
  • MRUS $46.36
  • EQX $6.92
  • Average True Range (ATR)
  • MRUS 2.58
  • EQX 0.24
  • MACD
  • MRUS -0.27
  • EQX -0.03
  • Stochastic Oscillator
  • MRUS 35.31
  • EQX 36.76

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About EQX Equinox Gold Corp.

Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.

Share on Social Networks: